Hutchmed (China)
HCM
Enerpac Tool
EPAC
Precision Drilling
PDS
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
BRNS Barinthus Biotherapeutics
- 0.805
- -0.168-17.27%
Close Apr 1 16:00 ET
- 0.790
- -0.015-1.81%
Post 16:05 ET
32.46MMarket Cap-0.52P/E (TTM)
0.973High0.791Low74.11KVolume0.973Open0.973Pre Close62.95KTurnover0.29%Turnover RatioLossP/E (Static)40.34MShares3.64052wk High0.25P/B20.91MFloat Cap0.79152wk Low--Dividend TTM25.98MShs Float17.990Historical High--Div YieldTTM18.71%Amplitude0.791Historical Low0.849Avg Price1Lot Size
Barinthus Biotherapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,766.46%14.97M | 0 | 14.97M | 0 | 0 | -98.21%802K | 0 | 0 | -98.04%334K | -96.88%468K |
| Operating revenue | 1,766.46%14.97M | --0 | --14.97M | --0 | --0 | -98.21%802K | --0 | --0 | -98.04%334K | -96.88%468K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -17.85%66.75M | -53.24%9.09M | 59.34%23.74M | -32.62%17.59M | -21.52%16.32M | 71.05%81.26M | -38.18%19.45M | 4,393.95%14.9M | 769.82%26.11M | 56.17%20.8M |
| Selling and administrative expenses | -25.53%29.67M | -77.56%3.06M | 1,296.46%13.42M | -45.15%7.2M | -50.62%5.99M | 523.12%39.84M | -29.69%13.62M | 108.89%961K | --13.13M | 231.37%12.14M |
| -General and administrative expense | -25.53%29.67M | -77.56%3.06M | 1,296.46%13.42M | -45.15%7.2M | -50.62%5.99M | 523.12%39.84M | -29.69%13.62M | 108.89%961K | --13.13M | 231.37%12.14M |
| Research and development costs | -7.63%38.25M | 6.67%6.22M | -24.45%10.53M | -15.52%10.97M | 21.65%10.53M | 0.74%41.41M | -51.77%5.83M | 33.16%13.94M | 45.99%12.98M | -10.32%8.66M |
| Other operating expenses | ---1.18M | ---184K | ---210K | ---577K | ---205K | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 35.64%-51.78M | 53.24%-9.09M | 41.13%-8.77M | 31.75%-17.59M | 19.71%-16.32M | -2,772.30%-80.45M | 22.22%-19.45M | -328.81%-14.9M | -283.33%-25.78M | -1,294.30%-20.33M |
| Net non-operating interest income expense | -7.86%2.63M | 10.82%625K | 224.87%614K | 22.64%623K | -51.95%763K | -7.62%2.85M | -56.78%564K | -81.74%189K | -23.26%508K | 17,544.44%1.59M |
| Non-operating interest income | -6.92%2.68M | 11.56%637K | 221.94%631K | 21.65%635K | -51.20%775K | -7.28%2.88M | -56.87%571K | -81.06%196K | -21.97%522K | 1,813.25%1.59M |
| Non-operating interest expense | 89.29%53K | 71.43%12K | 142.86%17K | -14.29%12K | --12K | 47.37%28K | --7K | --7K | 100.00%14K | --0 |
| Other net income (expense) | -1,215.90%-12.07M | -1,665.89%-12.12M | 1,400.00%26K | -93.55%20K | 90.83%1.08M | 50.00%774K | -2K | 507.84%310K | ||
| Special income (charges) | ---12.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --12.21M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -87.52%135K | -88.50%89K | 1,400.00%26K | -93.55%20K | ---- | 90.83%1.08M | 50.00%774K | ---2K | 507.84%310K | ---- |
| Income before tax | 19.99%-61.23M | -13.68%-20.59M | 44.73%-8.13M | 32.09%-16.95M | 16.98%-15.56M | -9,102.59%-76.52M | 21.88%-18.11M | -294.95%-14.71M | -268.95%-24.96M | -1,195.21%-18.74M |
| Income tax | 98.57%-44K | 100.37%3K | 99.50%-3K | 99.38%-7K | 92.83%-37K | 31.22%-3.08M | 59.39%-820K | 10.53%-603K | -24.15%-1.14M | 40.21%-516K |
| Net income | 16.70%-61.18M | -19.09%-20.59M | 42.39%-8.13M | 28.88%-16.94M | 14.83%-15.52M | -1,480.32%-73.45M | 18.30%-17.29M | -271.63%-14.11M | -251.85%-23.82M | -807.96%-18.22M |
| Net income continuous Operations | 16.70%-61.18M | -19.09%-20.59M | 42.39%-8.13M | 28.88%-16.94M | 14.83%-15.52M | -1,480.32%-73.45M | 18.30%-17.29M | -271.63%-14.11M | -251.85%-23.82M | -807.96%-18.22M |
| Minority interest income | -9.00%-109K | -1,800.00%-51K | 60.53%-15K | 45.45%-12K | 27.91%-31K | -376.19%-100K | -88.46%3K | -80.95%-38K | -450.00%-22K | -95.45%-43K |
| Net income attributable to the parent company | 16.73%-61.07M | -18.78%-20.54M | 42.34%-8.11M | 28.87%-16.93M | 14.80%-15.49M | -1,473.03%-73.35M | 18.39%-17.29M | -270.74%-14.07M | -251.67%-23.8M | -800.31%-18.18M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 16.73%-61.07M | -18.78%-20.54M | 42.34%-8.11M | 28.87%-16.93M | 14.80%-15.49M | -1,473.03%-73.35M | 18.39%-17.29M | -270.74%-14.07M | -251.67%-23.8M | -800.31%-18.18M |
| Basic earnings per share | 18.85%-1.55 | -13.33%-0.51 | 43.24%-0.21 | 30.65%-0.43 | 16.67%-0.4 | -1,464.29%-1.91 | 21.05%-0.45 | -268.18%-0.37 | -247.62%-0.62 | -785.71%-0.48 |
| Diluted earnings per share | 18.85%-1.55 | -13.33%-0.51 | 43.24%-0.21 | 30.65%-0.43 | 16.67%-0.4 | -1,464.29%-1.91 | 21.05%-0.45 | -268.18%-0.37 | -251.22%-0.62 | -805.88%-0.48 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call